BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 3615491)

  • 1. Survival rates and properties of sickle cell anemia red cells treated with nitrogen mustard.
    Roth EF; Wenz B; Lee HB; Fabry M; Chang H; Kaul DK; Baez S; Nagel RL
    Prog Clin Biol Res; 1987; 240():245-61. PubMed ID: 3615491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of pH on the rheologic and antisickling effects of dimethyl adipimidate.
    Pennathur-Das R; Lande WM; Mentzer WC; Mohandas N; Preisler H; Kleman KM; Heath RH; Lubin BH
    J Lab Clin Med; 1984 Nov; 104(5):718-29. PubMed ID: 6491469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Established and experimental treatments for sickle cell disease.
    De Franceschi L; Corrocher R
    Haematologica; 2004 Mar; 89(3):348-56. PubMed ID: 15020275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia.
    Ueda Y; Bookchin RM
    J Lab Clin Med; 1984 Aug; 104(2):146-59. PubMed ID: 6431043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate of deoxygenation modulates rheologic behavior of sickle red blood cells at a given mean corpuscular hemoglobin concentration.
    Kaul DK; Liu XD
    Clin Hemorheol Microcirc; 1999; 21(2):125-35. PubMed ID: 10599596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
    Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
    Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of methyl acetyl phosphate, a covalent antisickling agent, on the density profiles of sickle erythrocytes.
    Ueno H; Yatco E; Benjamin LJ; Manning JM
    J Lab Clin Med; 1992 Jul; 120(1):152-8. PubMed ID: 1613320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of methyl acetimidate as an extracorporeal antisickling agent.
    Chao TL; Berenfeld MR; Gabuzda TG
    Am J Pediatr Hematol Oncol; 1984; 6(1):55-8. PubMed ID: 6711765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood.
    Thurston GB; Henderson NM; Jeng M
    Clin Hemorheol Microcirc; 2004; 30(1):61-75. PubMed ID: 14967885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.
    Noguchi CT; Rodgers GP; Schechter AN
    Prog Clin Biol Res; 1987; 240():381-91. PubMed ID: 3615501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheological assessment of antisickling effects of pyridoxine and pyridoxal.
    Kuranstin-Mills J; Lessin LS
    Blood Cells; 1982; 8(2):315-28. PubMed ID: 7159755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of 2-imidazolines as anti-sickling agents.
    Chang H; Ewert SM; Nagel RL
    Mol Pharmacol; 1983 May; 23(3):731-4. PubMed ID: 6865916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
    Rodgers GP
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal treatment with cyanate in sickle cell disease: preliminary observations in four patients.
    Langer EE; Stamatoyannopoulos G; Hlastala MP; Adamson JW; Figley M; Labbe RF; Detter JC; Finch CA
    J Lab Clin Med; 1976 Mar; 87(3):462-74. PubMed ID: 1249477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of red cell membrane on the polymerization of sickle hemoglobin.
    Goldberg MA; Lalos AT; Himmelstein B; Bunn HF
    Blood Cells; 1982; 8(2):237-43. PubMed ID: 7159748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of GSTA2 protects against cell cycle arrest and apoptosis induced by the DNA inter-strand crosslinking nitrogen mustard, mechlorethamine.
    Xie J; Shults K; Flye L; Jiang F; Head DR; Briggs RC
    J Cell Biochem; 2005 May; 95(2):339-51. PubMed ID: 15778998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamic study of osmotic resistance of red cells in sickle cell anemia (author's transl)].
    Juhan I; Isnard G; Aquaron R
    Pathol Biol (Paris); 1976 Sep; 24(7):451-5. PubMed ID: 790270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation.
    Jensen M; Bunn HF; Halikas G; Kan YW; Nathan DG
    J Clin Invest; 1973 Oct; 52(10):2542-7. PubMed ID: 4729047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds.
    Safo MK; Abdulmalik O; Danso-Danquah R; Burnett JC; Nokuri S; Joshi GS; Musayev FN; Asakura T; Abraham DJ
    J Med Chem; 2004 Sep; 47(19):4665-76. PubMed ID: 15341482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of transfusion on hemoglobin flow and oxygen delivery in patients with sickle cell anemia--in vitro evaluation.
    McIntire LV; Leverett LB; Alfrey CP; Lynch EC; Zanger B
    Med Res Eng; 1980; 13(2):27-31. PubMed ID: 7401985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.